The UK’s Competition and Markets Authority has provisionally found that AMCo – now part of Advanz Pharma – as well as Morningside and wholesaler Alliance Healthcare “broke competition law by arranging to carve up the market between them” for nitrofurantoin from 2014 until at least 2017, according to a statement of objections revealed by the regulator this morning.
Pointing to the three firms’ “illegal market sharing” in the supply of the antibiotic, the CMA alleged that the companies...





